Fecal microbiota transplant for Clostridium difficile infection in older adults

Therapeutic Advances in Gastroenterology

Volumn 9, Issue 3, 2016, Pages 273-281

  Tauxe, William M ^a   Haydek, John P ^a   Rebolledo, Paulina A ^a,b   Neish, Emma ^c   Newman, Kira L ^c   Ward, Angela ^d   Dhere, Tanvi ^a   Kraft, Colleen S ^e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Clostridium difficile; fecal transplant; microbiota; older adults

Indexed keywords

ADVERSE OUTCOME; AGED; ARTHRITIS; ARTICLE; CAUSE OF DEATH; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE EXACERBATION; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT PLANNING;

EID: 84963748478     PISSN: 1756283X     EISSN: 17562848     Source Type: Journal    
DOI: 10.1177/1756283X15622600     Document Type: Article

References (39)

1. Agrawal M., Aroniadis O., Brandt L., Kelly C., Freeman S., Surawicz C., et al. (2015) The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated clostridium difficile infection in 146 elderly individuals. Journal of Clinical Gastroenterology Publish Ahead of Print
2. Bignardi G., (1998) Risk factors for Clostridium difficile infection. J Hosp Infect 40: 1-15.
3. Brandt L., Aroniadis O., Mellow M., Kanatzar A., Kelly C., Park T., et al. (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107: 1079-1087.
4. Brown K., Fisman D., Moineddin R., Daneman N., (2014) The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort study. PLoS One 9: e105454.
5. Caliskan R., Masatlioglu S., Aslan M., Altun S., Saribas S., Ergin S., et al. (2005) The relationship between arthritis and human parvovirus B19 infection. Rheumatol Int 26: 7-11.
6. Cammarota G., Ianiro G., Gasbarrini A., (2014) Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 48: 693-702.
7. Cammarota G., Masucci L., Ianiro G., Bibbò S., Dinoi G., Costamagna G., et al. (2015) Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Alimentary Pharmacology & Therapeutics 41: 835-843.
8. Cober E., Malani P., (2009) Clostridium difficile infection in the “oldest†old: clinical outcomes in patients aged 80 and older. J Am Geriatr Soc 57: 659-662.
9. Cohen S., Gerding D., Johnson S., Kelly C., Loo V., McDonald L., et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31: 431-455.
10. Drekonja D., Amundson W., Decarolis D., Kuskowski M., Lederle F., Johnson J., (2011) Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med 124: 1081.e1081-1087.
11. Drekonja D., Reich J., Gezahegn S., Greer N., Shaukat A., MacDonald R., et al. (2015) Fecal microbiota transplantation for Clostridium difficile infection: a systematic review. Ann Intern Med 162: 630-638.
12. Elixhauser A., Jhung M., (2006) Clostridium difficile-associated disease in U.S. hospitals, 1993-2005: Statistical Brief #50, Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research (US).
13. Elixhauser A., Steiner C., Gould C., (2006) Readmissions following hospitalizations with Clostridium difficile infections, 2009: Statistical Brief #145, Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research (US).
14. Friedman-Moraco R., Mehta A., Lyon G., Kraft C., (2014) Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients. Am J Transplant 14: 477-480.
15. Garborg K., Waagsbø B., Stallemo A., Matre J., Sundøy A., (2010) Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scandinavian Journal of Infectious Diseases 42: 857-861.
16. Gomez A., Luckey D., Yeoman C., Marietta E., Berg Miller M., Murray J., et al. (2012) Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One 7: e36095.
17. Guo B., Harstall C., Louie T., Veldhuyzen Van Zanten S., Dieleman L., (2012) Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 35: 865-875.
18. Kelly C., De Leon L., Jasutkar N., (2012) Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 46: 145-149.
19. Kelly C., Ihunnah C., Fischer M., Khoruts A., Surawicz C., Afzali A., et al. (2014) Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 109: 1065-1071.
20. Khan F., Elzouki A., (2014) Clostridium difficile infection: a review of the literature. Asian Pac J Trop Med 7s1: S6-s13.
21. Khoruts A., Dicksved J., Jansson J., Sadowsky M., (2010) Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44: 354-360.
22. Khoruts A., Sadowsky M., (2011) Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol 4: 4-7.
23. Louie T., Miller M., Crook D., Lentnek A., Bernard L., High K., et al. (2013) Effect of age on treatment outcomes in Clostridium difficile infection. J Am Geriatr Soc 61: 222-230.
24. Louie T., Miller M., Mullane K., Weiss K., Lentnek A., Golan Y., et al. (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364: 422-431.
25. Lucado J., Gould C., Elixhauser A., (2006) Clostridium difficile infections (CDI) in hospital stays, 2009: Statistical Brief #124, Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research (US).
26. Moore T., Rodriguez A., Bakken J., (2014) Fecal microbiota transplantation: a practical update for the infectious disease specialist. Clin Infect Dis 58: 541-545.
27. Nelson R., Kelsey P., Leeman H., Meardon N., Patel H., Paul K., et al. (2011) Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev: Cd004610.
28. Pepin J., Valiquette L., Cossette B., (2005) Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173: 1037-1042.
29. Scher J., Sczesnak A., Longman R., Segata N., Ubeda C., Bielski C., et al. (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2: e01202.
30. Solari P., Fairchild P., Noa L., Wallace M., (2014) Tempered enthusiasm for fecal transplant. Clin Infect Dis 59: 319.
31. Surawicz C., Brandt L., Binion D., Ananthakrishnan A., Curry S., Gilligan P., et al. (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108: 478-498; quiz 499.
32. Tello-Winniczuk N., Diaz-Jouanen E., Diaz-Borjon A., (2011) Parvovirus B19-associated arthritis: report on a community outbreak. J Clin Rheumatol 17: 449-450.
33. Van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E., De Vos W., et al. (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368: 407-415.
34. Vrieze A., Out C., Fuentes S., Jonker L., Reuling I., Kootte R., et al. (2014) Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 60: 824-831.
35. Walia R., Kunde S., Mahajan L., (2014) Fecal microbiota transplantation in the treatment of refractory clostridium difficile infection in children: an update. Curr Opin Pediatr 26: 573-578.
36. Wu H., Ivanov I, Darce J., Hattori K., Shima T., Umesaki Y., et al. (2010) Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32: 815-827.
37. Youngster I., Russell G., Pindar C., Ziv-Baran T., Sauk J., Hohmann E., (2014a) Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312: 1772-1778.
38. Youngster I., Sauk J., Pindar C., Wilson R., Kaplan J., Smith M., et al. (2014b) Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study. Clin Infect Dis 58: 1515-1522.
39. Zilberberg M., Reske K., Olsen M., Yan Y., Dubberke E., (2014) Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study. BMC Infect Dis 14: 306.